标题
Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 298, Issue 12, Pages 102700
出版商
Elsevier BV
发表日期
2022-11-14
DOI
10.1016/j.jbc.2022.102700
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer
- (2022) Fengyi Mao et al. PROSTATE
- Triggering a switch from basal- to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL1
- (2020) Minmin Fan et al. Cell Death & Disease
- Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility
- (2019) Jane Guan et al. CELL
- Discovery of Novel Celastrol Derivatives as Hsp90–Cdc37 Interaction Disruptors with Antitumor Activity
- (2019) Na Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations
- (2018) Rinath Jeselsohn et al. CANCER CELL
- Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner
- (2018) Frederick Zhehao Zhang et al. Oncotarget
- Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cells
- (2017) Jian Gao et al. Cell Death & Disease
- AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models
- (2016) H. M. Weir et al. CANCER RESEARCH
- High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
- (2016) Channing Yu et al. NATURE BIOTECHNOLOGY
- Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β
- (2016) Kendrick H. Yim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G
- (2015) Zibo Zhao et al. CHEMISTRY & BIOLOGY
- ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
- (2015) Rinath Jeselsohn et al. Nature Reviews Clinical Oncology
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Emergence of Constitutively Active Estrogen Receptor- Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
- (2014) R. Jeselsohn et al. CLINICAL CANCER RESEARCH
- Measuring Residual Estrogen Receptor Availability during Fulvestrant Therapy in Patients with Metastatic Breast Cancer
- (2014) Michel van Kruchten et al. Cancer Discovery
- Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation
- (2013) Y Zhang et al. BRITISH JOURNAL OF CANCER
- D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
- (2013) K. Merenbakh-Lamin et al. CANCER RESEARCH
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Activating ESR1 mutations in hormone-resistant metastatic breast cancer
- (2013) Dan R Robinson et al. NATURE GENETICS
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Phosphorylation by p38 Mitogen-Activated Protein Kinase Promotes Estrogen Receptor Turnover and Functional Activity via the SCFSkp2 Proteasomal Complex
- (2012) S. Bhatt et al. MOLECULAR AND CELLULAR BIOLOGY
- ERα Phosphorylation at Y537 by Src Triggers E6-AP-ERα Binding, ERα Ubiquitylation, Promoter Occupancy, and Target Gene Expression
- (2012) Jun Sun et al. MOLECULAR ENDOCRINOLOGY
- Withaferin A targets heat shock protein 90 in pancreatic cancer cells
- (2009) Yanke Yu et al. BIOCHEMICAL PHARMACOLOGY
- Tanespimycin: the opportunities and challenges of targeting heat shock protein 90
- (2009) Charles Erlichman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket
- (2008) Alison Donnelly et al. CURRENT MEDICINAL CHEMISTRY
- CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins
- (2008) Y. Morishima et al. HUMAN MOLECULAR GENETICS
- Development of Novobiocin Analogues That Manifest Anti-proliferative Activity against Several Cancer Cell Lines
- (2008) Joseph A. Burlison et al. JOURNAL OF ORGANIC CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started